Table 3. Diffences of clinical parameters after treatment.
| Variable | Visit (wk) | Maca (n=41) | p-valuea | Placebo (n=39) | p-valuea | p-valueb |
|---|---|---|---|---|---|---|
| Body weight (kg) | 0 | 68.88±9.49 | 69.19±8.01 | |||
| 12 | 69.30±9.27 | 0.1009 | 70.01±8.00 | 0.0127 | 0.1871 | |
| Waist circumference (cm) | 0 | 87.76±6.97 | 87.88±7.09 | |||
| 12 | 88.72±8.11 | 0.0269 | 88.57±6.88 | 0.0277 | 0.603 | |
| PSA (ng/mL) | 0 | 1.31±0.92 | 1.55±1.15 | |||
| 12 | 1.35±1.14 | 0.1509 | 1.45±0.97 | 0.1580 | 0.0569 | |
| Serum testosterone (ng/mL) | 0 | 4.40±1.64 | 5.46±1.88 | |||
| 12 | 4.41±1.76 | 0.9526 | 4.73±1.66 | 0.0156 | 0.444 | |
| Serum free testosterone (pg/mL) | 0 | 7.54±1.84 | 8.74±1.98 | |||
| 12 | 7.59±2.06 | 0.5295 | 8.33±2.74 | 0.3051 | 0.9184 | |
| Serum total cholesterol (mg/dL) | 0 | 161.66±32.42 | 179.97±35.42 | |||
| 12 | 159.44±37.31 | 0.3382 | 183.08±37.50 | 0.3441 | 0.1607 | |
| Serum HDL-C (mg/dL) | 0 | 49.37±10.60 | 50.49±11.36 | |||
| 12 | 48.51±9.58 | 0.3676 | 49.33±12.25 | 0.3127 | 0.9429 | |
| Serum LDL-C (mg/dL) | 0 | 88.63±28.78 | 103.51±31.54 | |||
| 12 | 89.44±33.26 | 0.6897 | 106.62±31.53 | 0.2595 | 0.3937 | |
| Serum triglyceride (mg/dL) | 0 | 110.27±68.36 | 119.85±65.98 | |||
| 12 | 96.59±40.42 | 0.1412 | 135.44±82.70 | 0.0878 | 0.0047 |
Values are presented as mean±standard deviation.
Maca: Lepidium meyenii, PSA: prostate specific antigen, HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol.
aCompared within groups (paired t-test).
bCompared between groups (adjusted baseline).